268 results on '"Droin, N."'
Search Results
2. Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer
3. Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: CMML PATIENTS WITH LOW EXPRESSION OF TP53 POINT TO AML TRANSFORMATION
4. HETEROCHROMATIN CHANGES IN HSCS FROM CMML PATIENTS CONFER SENSITIVITY TO THE COMBINATION OF G9A/GLP INHIBITORS AND DNA HYPOMETHYLATING AGENTS VIA DEREPRESSION OF RETROELEMENTS
5. Topic: AS04-MDS Biology and Pathogenesis/AS04e-Spliceosome machinery: DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION
6. Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: CALPROTECTIN (S100A8/A9) EFFECTS ON HEALTHY CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS ARE AMPLIFIED IN CHRONIC MYELOID MALIGNANCIES
7. Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: CXCL8 SECRETED BY IMMATURE GRANULOCYTES INHIBITS WILD-TYPE STEM AND PROGENITOR CELL EXPANSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
8. Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: IMPROVING THE CLONAL EVOLUTION MODEL: THE CASE OF CMML
9. Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS OF THE BONE MARROW NICHE CONTRIBUTE TO THE PROINFLAMMATORY PHENOTYPE OF CMML MONOCYTES THROUGH IGFBP2
10. 2O Dissecting intratumoral heterogeneity in localized HR+/HER2- breast cancer using single-cell DNA sequencing (scDNA-seq)
11. P084 - Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS OF THE BONE MARROW NICHE CONTRIBUTE TO THE PROINFLAMMATORY PHENOTYPE OF CMML MONOCYTES THROUGH IGFBP2
12. P079 - Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: CXCL8 SECRETED BY IMMATURE GRANULOCYTES INHIBITS WILD-TYPE STEM AND PROGENITOR CELL EXPANSION IN CHRONIC MYELOMONOCYTIC LEUKEMIA
13. P062 - Topic: AS04-MDS Biology and Pathogenesis/AS04f-Gene expression profiling: CMML PATIENTS WITH LOW EXPRESSION OF TP53 POINT TO AML TRANSFORMATION
14. P057 - Topic: AS04-MDS Biology and Pathogenesis/AS04e-Spliceosome machinery: DNA REPLICATION STRESS DUE TO LOSS OF R-LOOPS IN MYELODYSPLASTIC SYNDROMES WITH SF3B1 MUTATION
15. P044 - Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: IMPROVING THE CLONAL EVOLUTION MODEL: THE CASE OF CMML
16. P036 - Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: CALPROTECTIN (S100A8/A9) EFFECTS ON HEALTHY CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS ARE AMPLIFIED IN CHRONIC MYELOID MALIGNANCIES
17. O15 - HETEROCHROMATIN CHANGES IN HSCS FROM CMML PATIENTS CONFER SENSITIVITY TO THE COMBINATION OF G9A/GLP INHIBITORS AND DNA HYPOMETHYLATING AGENTS VIA DEREPRESSION OF RETROELEMENTS
18. 138P Dissecting intra-tumoral heterogeneity in localized HR+/Her2− breast cancer using single cell DNA sequencing
19. LBA72 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial
20. 1672P Tumor and immune cell dynamics at single-cell resolution on combined PARP inhibition and anti-PD-L1 therapy
21. 1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma
22. 343MO Unraveling the mechanisms of action and resistance to trastuzumab deruxtecan (T-DXd): Supplementary biomarker analyses from DAISY trial
23. DNMT3AR882H mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice
24. Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes
25. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment
26. Caspases/NOX2 axis: a potential target to modulate macrophage polarization: 6.72
27. 1732MO Pembrolizumab and nintedanib for patients with advanced mesothelioma
28. 1773P Anti-PD1-induced acute interstitial pneumonitis is characterized by alveolar infiltration of PD-1+CD38+TIGIT+ cytotoxic effector CD8+ T cells and CD206+ inflammatory macrophages
29. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression
30. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
31. Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
32. Procaspase-2S inhibits procaspase-3 processing and activation, preventing ROCK-1-mediated apoptotic blebbing and body formation in human B lymphoma Namalwa cells
33. SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
34. Positive and negative regulation of apoptotic pathways by cytotoxic agents in hematological malignancies
35. 1591P Whole exome sequencing: Evolution of indications and cost to inform public health policy decision-making
36. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis
37. Proteases, proteolysis, and apoptosis
38. Ontogenic changes in hematopoietic hierarchy determine pediatric specificity and disease phenotype in fusion oncogene– driven myeloid leukemia
39. Detection of PIK3CA mutation by circulating DNA during chemotherapy: A tool to identify hard-to-treat metastatic breast cancers
40. Comparison of molecular profiles between primary tumour and matched metastasis in non-small cell lung cancer
41. PB1868 B-CELL PROLYMPHOCYTIC LEUKEMIA (B-PLL) AND PROLYMPHOCYTOID MANTLE CELL LYMPHOMA (PMCL) (MORE THAN 55% OF PROLYMPHOCYTES) ARE CLOSED BUT DISTINCT ENTITIES. ON BEHALF GFCH AND FILO GROUPS
42. Outcome and mutational landscape of patients with PIK3CA-mutated metastatic breast cancer (mBC)
43. Le principe de non-discrimination:l'analyse des discours
44. 92P - Detection of PIK3CA mutation by circulating DNA during chemotherapy: A tool to identify hard-to-treat metastatic breast cancers
45. 1965P - Comparison of molecular profiles between primary tumour and matched metastasis in non-small cell lung cancer
46. Conseil médical en environnement intérieur (CMEI) en Bourgogne : amélioration du risque allergénique de l’habitat et diminution de la consommation médicamenteuse chez 686 patients
47. 23 DOWN-REGULATION OF MIR150 PROMOTES THE ACCUMULATION OF CLASSICAL MONOCYTES, A CHARACTERISTIC FEATURE OF CHRONIC MYELOMONOCYTIC LEUKEMIA
48. A role for caspases in the differentiation of erythroid cells and macrophages
49. Use of the 46/1 haplotype to model JAK2V617F clonal architecture in PV patients: clonal evolution and impact of IFNα treatment
50. P-004 SETBP1 mutations in 658 patients with myeldodysplastic syndromes, chronic myelomonocytic leukemia and secondary AML
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.